mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.005 |
mRNA |
NSC95397 |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.006 |
mRNA |
pac-1 |
CTRPv2 |
pan-cancer |
AAC |
0.098 |
0.006 |
mRNA |
Compound 23 citrate |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.006 |
mRNA |
BRD-K04800985 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.007 |
mRNA |
CH5424802 |
GDSC1000 |
pan-cancer |
AAC |
0.092 |
0.007 |
mRNA |
NSC23766 |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.008 |
mRNA |
Bortezomib |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.008 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.086 |
0.008 |
mRNA |
SMER-3 |
CTRPv2 |
pan-cancer |
AAC |
0.099 |
0.009 |